Our advanced genomic services support the identification and interpretation of genetic variations and their implications for health and disease.
We analyze genetic mutations to determine their potential impact on health, providing insights into disease mechanisms and potential therapeutic targets.
We assess next-generation sequencing (NGS) data to identify and quantify insertions and deletions (indels) induced by CRISPR-Cas gene editing.
Our team retrieves and analyzes genomic sequences to identify genetic variants and their functional consequences.
We evaluate the outcomes of gene editing experiments, linking genetic changes to phenotypic effects to understand the impact of specific edits.